Benign Skin Vascular Neoplasm

subtype

Identifier: CI-CAN-00001947
Entity page: /cancer/benign-skin-vascular-neoplasm ↗
Edges: 4

Neighbours: 2 drugs2 trials
Drawn: 4 of 4 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Benign Skin Vascular Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived2 of 2
→ investigated in trials for	Sirolimussmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Benign Skin Vascular Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Vincristinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants

Benign Skin Vascular Neoplasm studied in …STUDIED_INderived2 of 2
→ studied in	NCT00975819Phase 2 · completed Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies · condition mapped ALIAS · 2 trials mapped (0 active)	—	—	Tufted Hemangioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02110069Phase 2 · terminated A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors · condition mapped ALIAS · 2 trials mapped (0 active)	—	—	Tufted Hemangioma	1	Observed	clinicaltrials	graph →

Benign Skin Vascular Neoplasm studied in …STUDIED_INderived2 of 2

→ studied in

NCT00975819Phase 2 · completed

Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies · condition mapped ALIAS · 2 trials mapped (0 active)

—

Tufted Hemangioma

Observed

clinicaltrials

graph →

→ studied in

NCT02110069Phase 2 · terminated

A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors · condition mapped ALIAS · 2 trials mapped (0 active)